Compare BFH & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFH | MMSI |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.1B |
| IPO Year | 2000 | 1996 |
| Metric | BFH | MMSI |
|---|---|---|
| Price | $95.48 | $70.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 8 |
| Target Price | $80.64 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 770.2K | 768.3K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | ★ 98.36 | 4.93 |
| EPS | ★ 4.15 | 0.68 |
| Revenue | ★ $4,521,400,000.00 | $1,515,906,000.00 |
| Revenue This Year | $53.25 | $8.85 |
| Revenue Next Year | $3.53 | $5.88 |
| P/E Ratio | ★ $22.61 | $104.50 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $53.90 | $59.74 |
| 52 Week High | $109.91 | $94.75 |
| Indicator | BFH | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 59.32 |
| Support Level | $82.58 | $66.19 |
| Resistance Level | $99.13 | $71.96 |
| Average True Range (ATR) | 3.57 | 1.91 |
| MACD | -1.67 | 0.15 |
| Stochastic Oscillator | 22.23 | 75.71 |
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.